Usfda
Biogen seeks US approval for potential Alzheimer's drug, stock jumps
Debate on drug to treat Covid-19 politicised; India uses it: White House
FDA chief declines to back Donald Trump's 'harmless' coronavirus claim
Policy flip-flops may puncture India's image as 'pharmacy of the world'
Sequoia-backed Qure.ai gets USFDA nod for CT scan, first for Indian AI firm

USFDA to release guidance on Covid-19 vaccine approval: Report
Zydus Cadila gets USFDA nod to market generic antihistamine tablets
USFDA removes partial lifting of import on API facility at Ratlam: Ipca Lab
Shot of Hope: Equal access a hurdle after race to coronavirus vaccine
Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets

Covid-19 crisis: Cipla launches generic remdesivir under brand name Cipremi
Unichem, Lupin recall high blood pressure drugs from US over quality issues
Piramal Pharma Solutions to acquire G&W Laboratories' drug facility in US
Cadila Healthcare's Q4 PBT falls 14% to Rs 522 cr, total income rises 0.66%
Alembic Pharma gets USFDA nod for generic Adapalene gel for acne treatment
Glenmark Pharma gets USFDA nod for drug to treat multiple sclerosis
Sun Pharma, Hikma ink pact for plaque psoriasis drug for MENA region
Dr Reddy's inks pact with Gilead to manufacture, market Remdesivir in India
Gilead finds fourth partner for manufacture of Remdesivir in Zydus Cadila
Biocon gets a shot in the arm with FDA approval for insulin glargine